Format

Send to

Choose Destination
Emerg Infect Dis. 2013 Aug;19(8):1206-13. doi: 10.3201/eid.1908.130257.

Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands.

Author information

1
Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands. s.paltansing@lumc.nl

Abstract

A prospective cohort study was performed among travelers from the Netherlands to investigate the acquisition of carbapenemase-producing Enterobacteriaceae (CP-E) and extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and associated risk factors. Questionnaires were administered and rectal swab samples were collected and tested before and after traveler return. Of 370 travelers, 32 (8.6%) were colonized with ESBL-E before trave,; 113 (30.5%) acquired an ESBL-E during travel, and 26 were still colonized 6 months after return. No CP-E were found. Independent risk factors for ESBL-E acquisition were travel to South and East Asia. Multilocus sequence typing showed extensive genetic diversity among Escherichia coli. Predominant ESBLs were CTX-M enzymes. The acquisition rate, 30.5%, of ESBL-E in travelers from the Netherlands to all destinations studied was high. Active surveillance for ESBL-E and CP-E and contact isolation precautions may be recommended at admission to medical facilities for patients who traveled to Asia during the previous 6 months.

KEYWORDS:

CP-E; ESBL; ESBL-E; Enterobacteriaceae; Escherichia coli; Holland; Klebsiella pneumoniae; antibiotic; antimicrobial resistance; bacteria; carbapenemase; extended-spectrum β-lactamase; sequence type; the Netherlands; travel health; travelers

PMID:
23885972
PMCID:
PMC3739527
DOI:
10.3201/eid.1908.130257
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center